|
Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886 EISSN: 0028-3886
Vol. 56, No. 3, 2008, pp. 333-338
|
Bioline Code: ni08084
Full paper language: English
Document type: Review Article
Document available free of charge
|
|
Neurology India, Vol. 56, No. 3, 2008, pp. 333-338
en |
Two eminently treatable genetic metabolic myopathies
Yee, Woon-Chee
Abstract
Treatment of the genetic metabolic myopathies remains generally unsatisfactory with the exception of a select few. Multiple Acyl Co-A Dehydrogenase Deficiency (Glutaric Aciduria type II), in particular, has been shown to respond well to riboflavin supplementation. Recently, studies have also confirmed the effectiveness of recombinant enzyme replacement therapy for Acid Maltase Deficiency (Pompe′s Disease). Accurate and early diagnosis of these diseases is vital to prevent serious complications and impaired recovery following delayed treatment.
Keywords
Acid maltase deficiency, enzyme replacement therapy, glutaric aciduria Type II, human recombinant α-glucosidase, multiple Co-A dehydrogenase deficiency, Pompe disease, riboflavin
|
|
© Copyright 2008 Neurology India. Alternative site location: http://www.neurologyindia.com
|
|